PUBLIC COMPANY
save$SKYESkye Bioscience, Inc.
$SKYESan Diego, CA, USupdated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
- Redx tries again at reverse merger, with Skye this time, as route gains steamUK fibrosis biotech Redx Pharma is making another go at a reverse merger, after its last attempt was axed in 2023. The ROCK inhibitor developer will take the Nasdaq listing of Skye ...endpoints · 1mo ago
- Skye and Redx form new entity with $125M to advance fibrosis assetsSkye Bioscience has entered into an agreement to combine with privately held fibrotic disease biotech Redx Pharma in a deal that will net $125 million in financing for the new public company, calle…fiercebiotech · 1mo ago
Data sources
last refreshed 58m ago
Found something off?
comments(0)
5-min edit window · permanent after that